Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.337 USD | -0.22% | -5.17% | +14.28% |
Apr. 16 | Clearside Biomedical, Inc Appoints Anthony S. Gibney to its Board of Directors | CI |
Mar. 18 | Clearside Biomedical Names Victor Chong Chief Medical Officer | MT |
Financials (USD)
Sales 2024 * | 2.74M | Sales 2025 * | 7.36M | Capitalization | 100M |
---|---|---|---|---|---|
Net income 2024 * | -39M | Net income 2025 * | -43M | EV / Sales 2024 * | 28.8 x |
Net cash position 2024 * | 21.26M | Net Debt 2025 * | 12.33M | EV / Sales 2025 * | 15.3 x |
P/E ratio 2024 * |
-2.55
x | P/E ratio 2025 * |
-2.31
x | Employees | 30 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.7% |
Latest transcript on Clearside Biomedical, Inc.
1 day | -0.22% | ||
1 week | -5.17% | ||
Current month | -12.61% | ||
1 month | -15.37% | ||
3 months | +2.85% | ||
6 months | +94.06% | ||
Current year | +14.28% |
Managers | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 11-12-31 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 17-08-07 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 18-09-25 |
Christy Shaffer
BRD | Director/Board Member | 66 | 11-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.337 | -0.22% | 32 402 |
24-04-26 | 1.34 | +6.35% | 154,219 |
24-04-25 | 1.26 | -5.97% | 135,399 |
24-04-24 | 1.34 | -2.19% | 201,427 |
24-04-23 | 1.37 | -2.84% | 232,166 |
Delayed Quote Nasdaq, April 29, 2024 at 10:28 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.28% | 100M | |
-2.42% | 103B | |
+1.67% | 95.28B | |
+2.13% | 22.15B | |
-15.77% | 21.02B | |
-8.40% | 18.15B | |
-41.01% | 16.73B | |
-13.73% | 16.05B | |
+4.00% | 13.68B | |
+34.74% | 12.17B |
- Stock Market
- Equities
- CLSD Stock